| 000 | 01099 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250518100310.0 | ||
| 264 | 0 | _c20210319 | |
| 008 | 202103s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/1381612826666200422093213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHao, Dongsheng | |
| 245 | 0 | 0 |
_aBisphosphonates Can Maintain Periprosthetic Bone Mass Density after Total Hip Replacement, with Controversy in Region of Interest 5. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2020 |
||
| 300 |
_a4925-4933 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Systematic Review | ||
| 650 | 0 | 4 | _aArthroplasty, Replacement, Hip |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 | _aBone Density Conservation Agents |
| 650 | 0 | 4 | _aDiphosphonates |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOsteoporosis |
| 700 | 1 | _aWang, Junjie | |
| 700 | 1 | _aZuo, Liyun | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 26 _gno. 38 _gp. 4925-4933 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612826666200422093213 _zAvailable from publisher's website |
| 999 |
_c30887795 _d30887795 |
||